B.F. S.P.A. financials
B.F. S.P.A.
Country: IT Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
815600DADF851874C681 Financial statements
(EUR, as reported — unscaled; 103 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.63B | €1.41B |
| Gross profit | €1.73B | €1.50B |
| Other income | €87.6M | €90.5M |
| Operating expenses | €1.68B | €1.46B |
| Employee benefits expense | €84.1M | €74.9M |
| Raw materials & consumables used | €1.28B | €1.08B |
| Operating profit (EBIT) | €53.6M | €46.6M |
| Finance costs | €37.1M | €38.0M |
| Profit before tax | €25.7M | €19.3M |
| Income tax expense | €10.3M | €6.0M |
| Profit for the year | €15.5M | €13.4M |
| — attributable to owners | €11.2M | €10.4M |
| — attributable to NCI | €4.3M | €3.0M |
| Total comprehensive income | €15.5M | €12.0M |
| Cash flow statement | ||
| Net cash from operating activities | -€7.0M | -€21.1M |
| Income taxes paid | €6.5M | €2.6M |
| Net cash from investing activities | -€54.9M | -€183.7M |
| Net cash from financing activities | €170.0M | €126.1M |
| Dividends paid | €22.9M | €15.8M |
| Lease liability payments | €10.3M | €11.5M |
| Balance sheet | ||
| Total assets | €2.63B | €2.34B |
| Non-current assets | €1.32B | €1.24B |
| Property, plant & equipment | €620.8M | €608.3M |
| Intangible assets & goodwill | €70.7M | €100.1M |
| Current assets | €1.31B | €1.08B |
| Inventories | €297.7M | €282.0M |
| Trade & other receivables | €457.6M | €365.2M |
| Cash & equivalents | €375.8M | €267.8M |
| Total equity | €1.22B | €1.04B |
| — attributable to owners | €800.5M | €793.7M |
| Non-controlling interests | €421.1M | €243.4M |
| Non-current liabilities | €402.3M | €391.0M |
| Long-term borrowings | €195.2M | €167.9M |
| Current liabilities | €1.01B | €906.8M |
| Short-term borrowings | €224.0M | €227.3M |
| Derived metrics | ||
| Operating margin | 3.3% | 3.3% |
| Net margin | 0.9% | 0.9% |
| Return on equity | 1.3% | 1.3% |
| Cash conversion ratio | -0.45× | -1.58× |
| Other reported items | ||
| Adjustments For Decrease Increase In Biological Assets | -€2.8M | -€235.0K |
| Adjustments For Decrease Increase In Inventories | -€19.8M | €26.8M |
| Adjustments For Decrease Increase In Other Current Assets | -€15.8M | -€40.7M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€94.4M | -€25.0M |
| Adjustments For Depreciation and Amortisation Expense | €53.9M | €45.9M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | €22.6M | €4.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | €3.1M | €3.4M |
| Adjustments For Increase Decrease In Other Current Liabilities | -€17.3M | €9.4M |
| Adjustments For Increase Decrease In Trade Account Payable | €106.1M | €8.1M |
| Adjustments For Interest Expense | €27.8M | €27.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -€50.3M | -€20.6M |
| Adjustments For Provisions | -€2.7M | -€1.7M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€564.0K | €35.6M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €81.4M | €44.4M |
| Comprehensive Income Attributable To Noncontrolling Interests | €4.4M | €2.5M |
| Comprehensive Income Attributable To Owners of Parent | €11.1M | €9.5M |
| Current Biological Assets | €17.8M | €15.1M |
| Current Contract Assets | €14.0M | €11.0M |
| Current Financial Assets | €17.5M | €16.6M |
| Dividends Received Classified As Investing Activities | €2.3M | €875.0K |
| Dividends Recognised As Distributions To Noncontrolling Interests | €4.7M | €5.7M |
| Equity and Liabilities | €2.63B | €2.34B |
| Finance Costs Paid Classified As Operating Activities | €31.0M | €35.1M |
| Finance Income | €9.3M | €10.8M |
| Increase Decrease In Cash and Cash Equivalents | €108.1M | -€78.7M |
| Increase Decrease In Working Capital | €44.0M | €21.6M |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Change In Equity of Subsidiaries | €85.4M | — |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €1.8M | €38.8M |
| Increase Decrease Through Disposal of Subsidiary | €85.8M | €62.1M |
| Increase Decrease Through Exercise of Options | €23.9M | -€309.0K |
| Increase Decrease Through Sharebased Payment Transactions | €1.2M | €990.0K |
| Increase Decrease Through Transactions With Owners | — | €0 |
| Intangible Assets Other Than Goodwill | €186.7M | €166.3M |
| Interest Received Classified As Investing Activities | €3.2M | €6.9M |
| Investment Property | €26.1M | €23.1M |
| Issued Capital | €261.9M | €261.9M |
| Liabilities Included In Disposal Groups Classified As Held For Sale | €0 | €360.0K |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | €4.8M | €22.6M |
| Noncurrent Biological Assets | €2.9M | €5.3M |
| Noncurrent Provisions For Employee Benefits | €8.9M | €10.7M |
| Noncurrent Receivables | €117.5M | €87.2M |
| Other Comprehensive Income | €48.0K | -€1.4M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | €317.0K | -€1.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€192.0K | -€333.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€77.0K | €75.0K |
| Other Current Assets | €131.2M | €118.5M |
| Other Current Payables | €99.4M | €99.5M |
| Other Expense By Nature | €33.2M | €38.6M |
| Other Longterm Provisions | €25.6M | €21.7M |
| Other Noncurrent Payables | €95.1M | €123.0M |
| Other Reserves | €539.5M | €505.3M |
| Other Work Performed By Entity and Capitalised | €8.4M | €6.8M |
| Proceeds From Changes In Ownership Interests In Subsidiaries | €89.0M | €28.8M |
| Proceeds From Current Borrowings | €0 | €37.3M |
| Proceeds From Issuing Shares | €0 | €0 |
| Proceeds From Noncurrent Borrowings | €118.4M | €125.0M |
| Repayments of Current Borrowings | €0 | €0 |
| Repayments of Noncurrent Borrowings | €88.4M | €75.8M |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€12.1M | €16.1M |
| Retained Earnings Profit Loss For Reporting Period | €11.2M | €10.4M |
| Services Expense | €227.3M | €194.3M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €417.0K | -€364.0K |
| Trade and Other Current Payables To Trade Suppliers | €686.3M | €580.1M |
Methodology
Every line item above is a fact tagged in B.F. S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.